Last 1,474 INR
Change Today 0.00 / 0.00%
Volume 0.0
DIVI On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

divi's laboratories ltd (DIVI) Snapshot

Open
1,460
Previous Close
1,477
Day High
1,503
Day Low
1,452
52 Week High
07/7/14 - 1,549
52 Week Low
08/5/13 - 905.00
Market Cap
195.7B
Average Volume 10 Days
209.0K
EPS TTM
58.26
Shares Outstanding
132.7M
EX-Date
--
P/E TM
25.3x
Dividend
20.00
Dividend Yield
1.02%
Current Stock Chart for DIVI'S LABORATORIES LTD (DIVI)

Related News

No related news articles were found.

divi's laboratories ltd (DIVI) Related Businessweek News

No Related Businessweek News Found

divi's laboratories ltd (DIVI) Details

Divi’s Laboratories Limited manufactures active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin, canthaxanthin, etc.; neutraceuticals; protected amino acids comprising BOC, FMOC, and CBZ; and novel ligands, including binol and binap. The company also offers custom synthesis of API and advanced intermediates for discovery compounds to pharma companies. It also exports its products primarily to European and the American countries. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.

Founded in 1990

divi's laboratories ltd (DIVI) Top Compensated Officers

Chairman and Managing Director
Total Annual Compensation: 9.0M
President of Operations, Director of Operatio...
Total Annual Compensation: 7.8M
Executive Director and Member of Shareholders...
Total Annual Compensation: 8.4M
Director of Projects and Executive Director
Total Annual Compensation: 7.8M
Compensation as of Fiscal Year 2013.

divi's laboratories ltd (DIVI) Key Developments

Divi's Laboratories Limited Announces Executive Changes

Divi's Laboratories Limited announced that the board of directors of the company at its meeting held on June 23, 2014, has appointed Sri. K. V. K. Seshavataram and Smt. S. Sridevi as Additional Directors (Independent and Non-Executive) on the Board of the company effective from June 23, 2014. Further the company announced that, Dr. K. Satyanarayana and Sri. S. Vasudev, Independent Directors of the company have resigned from the board of the company effective from June 23, 2014 due to personal reasons and other pre-occupations.

Divi's Laboratories Limited, Board Meeting, Jun 23, 2014

Divi's Laboratories Limited, Board Meeting, Jun 23, 2014. Agenda: To approve the appointment of Mr. K.V.K. Seshavataram and Mrs. S. Sridevi as additional independent and non-executive directors and resignations of K. Satyanarayana and S. Vasudev as independent directors.

Divi's Laboratories Limited Announces Audited Standalone and Consolidated Earnings Results for the Fourth Quarter and Year Ended March 31, 2014

Divi's Laboratories Limited announced audited standalone and consolidated earnings results for the fourth quarter and year ended March 31, 2014. On standalone basis, for the quarter, the company reported net sales/income from operations of INR 7,380.1 million against INR 6,496.1 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 2,364.3 million against INR 2,321.1 million a year ago. Profit from ordinary activities before tax was INR 2,449.0 million against INR 2,390.8 million a year ago. Net profit for the period was INR 1,930.6 million or INR 14.54 per basic and diluted share before and after extraordinary items against INR 1,818.3 million or INR 13.70 per basic and diluted share before and after extraordinary items a year ago. For the year, the company reported net sales/income from operations of INR 25,071.8 million against INR 21,239.5 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 9,268.0 million against INR 7,448.5 million a year ago. Profit from ordinary activities before tax was INR 10,086.4 million against INR 7,915.8 million a year ago. Net profit for the period was INR 7,917.2 million or INR 59.65 per basic and diluted share before and after extraordinary items against INR 6,114.2 million or INR 46.06 per basic and diluted share before and after extraordinary items a year ago. On consolidated basis, for the quarter, the company reported net sales/income from operations of INR 7,476.2 million against INR 6,558.3 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 2,404.6 million against INR 2,299.1 million a year ago. Profit from ordinary activities before tax was INR 2,489.3 million against INR 2,368.9 million a year ago. Net profit for the period was INR 1,964.3 million or INR 14.80 per basic and diluted share before and after extraordinary items against INR 1,805.7 or INR 13.60 per basic and diluted share before and after extraordinary items a year ago. For the year, the company reported net sales/income from operations of INR 25,253.5 million against INR 21,399.0 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 9,223.7 million against INR 7,382.1 million a year ago. Profit from ordinary activities before tax was INR 9,909.2 million against INR 7,812.4 million a year ago. Net profit for the period was INR 7,733.4 million or INR 58.26 per basic and diluted share before and after extraordinary items against INR 6,020.1 million or INR 45.35 per basic and diluted share before and after extraordinary items a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DIVI:IN 1,474.20 INR 0.00

DIVI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biocon Ltd 484.45 INR 0.00
Dishman Pharmaceuticals & Chemicals Ltd 121.40 INR 0.00
Piramal Enterprises Ltd 695.95 INR 0.00
Shasun Pharmaceuticals Ltd 160.05 INR 0.00
Torrent Pharmaceuticals Ltd 676.10 INR 0.00
View Industry Companies
 

Industry Analysis

DIVI

Industry Average

Valuation DIVI Industry Range
Price/Earnings 25.2x
Price/Sales 7.7x
Price/Book 6.6x
Price/Cash Flow 22.5x
TEV/Sales 7.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIVI'S LABORATORIES LTD, please visit www.divislabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.